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DRHM® is a polyherbal formulation [composed of Cymbopogon citratus (17%), Carica papaya leaves (16%), Mangifera 
indica bark (15%), Moringa oleifera leaves (14%), Citrus limon (12%), Psidium guajava (11%), Zingiber officinale root (9%) and 
Allium sativum (6%)] that is indicated for many disease conditions and as a detoxifier. In this study, the effects of DRHM® on 
hydrogen peroxide (3 mL/kg b.w of 5% H2O2, i.p)-induced hematological and biochemical aberrations in rats were evaluated. H2O2 
significantly (p<0.05) reduced hemoglobin level, packed cell volume and red blood cell, white blood cell and platelet counts. It 
elevated the activities of aspartate and alanine aminotransferases and levels of total bilirubin and malondialdehyde. In addition, 
H2O2 also decreased superoxide dismutase, catalase and glutathione peroxidase activities and reduced glutathione and antioxidant 
vitamins levels. However, after 14 days of treatment at 1, 2 and 3 mL/kg/d b.w. p.o, DRHM® reversed aberrations in hematological 
status, enhanced antioxidant status and attenuated lipid peroxidation and hepatic damage induced by H2O2, in a dose-dependent 
manner comparable to silymarin (100 mg/kg/d. b.w.). These findings suggest that the phytoconstituents in DRHM® might be 
responsible for these ameliorative effects by boosting antioxidant defense system. DRHM® was tolerable up to 10 mL/kg. b.w. 
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The excessive generation of free radicals beyond the 
level in which natural antioxidant defense of the body 
can neutralize them results in oxidative stress, a 
condition that is linked with pathogenesis of 
cardiovascular diseases, ageing and diabetes1. These 
damages usually occur via., inactivation of key 
metabolic enzymes and damages to important cellular 
macromolecules, often resulting in devastating 
consequences2. The liver helps in the detoxification 
and removal of xenobiotics, some of which are 
potentially toxic3. This exposes the liver to injury 
leading to the impairment of its functions in the 
presence of hepatotoxins. The burden of liver diseases 
is high because damage to this vital metabolic organ 
has serious implications to the entire health and 
wellbeing4. One major mechanism of xenobiotic-
induced liver damage is radical species-mediated, 
leading to oxidative damage to the hepatocytes. 
Hepatotoxicity is usually characterized by necrosis of 
hepatocytes, elevation in lipid peroxidation and 
decrease in reduced glutathione (GSH) concentration. 
The serum bilirubin and lipid profile and activities of 
transaminases and alkaline phosphatase are markedly 
increased during liver damage5. Aberrations in 
hematological indices such as reduced red blood cell 
(RBC) and white blood cell (WBC) counts, packed 
cell volume (PCV) and hemoglobin (Hb) concentration 
are also recorded in oxidative stress6. Interestingly, 
the dietary supplementation with antioxidants-rich 
agents has been suggested to be beneficial in 
abrogating radical species-related cellular assaults7.  
The use of herbal remedies for the management of 
diseases is increasing globally due to a widespread 
perception that herbal drugs have little or no side 
effect, making them a first consideration in some 
African and Asian populations for treating many 
diseases8,9. Traditional remedies are usually made up 
of only one part of the plant. However, accumulation 
of therapeutic experience and the search for improved 
health outcomes by herbal practitioners over time 
have resulted in a shift from the use of a single plant 
or plant parts to the combination of different plants or 
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parts of plant for enhanced therapeutic potentials10. 
This involves the use of specific proportions of 
leaves, stem, seeds and roots of different plants in 
water, alcohol or other non-toxic solvents. It is 
believed that the active principles in these plants work 
synergistically or in combination to produce enhanced 
therapeutic effect11. 
Nigerian drug stores are enriched with several 
branded polyherbal formulations. One of such 
polyherbal formulations that have flooded drug 
markets in Nigeria and many parts of Africa is 
DRHM®. It is acclaimed by the manufacturer to be a 
potent detoxifier and blood booster. It is also claimed 
to be effective in the management of disease 
conditions such as malaria, typhoid, viral, bacterial 
and fungal infections, menstrual problems and low 
sperm count. Despite the prevalent use of this 
polyherbal formulation, there is no empirical evidence 
of the above claims and the safety profile has not been 
documented, to the best of our knowledge. This study 
evaluated the effects of DRHM® on H2O2-induced 
hematological and biochemical aberrations in rats. 
The acute toxicity profile and phytochemical constituents 
of the polyherbal formulation were also assessed. 
 
Materials and Methods 
 
Materials 
All the chemicals used for this study were products 
of BDH Chemical Ltd. (Poole, England) and Sigma 
Aldrich (USA); they were all of analytical grades. 
Drugs used for this study were DRHM® and 
silymarin. They were purchased from reputable drug 
stores in Enugu State, Nigeria. Reagents used for this 
study were products of Randox Laboratories (USA) 
and QCA (Germany).  
 
Phytochemical analyses of DRHM® 
Methods previously described12 were used for the 
detection and quantification of the phytochemical 
constituents of DRHM®. 
 
Determination of acute toxicity profile of DRHM® 
This was done using twenty healthy male Swiss 
albino mice of body weight range 25-30 g. They were 
sourced from the Department of Zoology and 
Environmental Biology, University of Nigeria, Nsukka. 
After seven days of acclimatization to laboratory 
environment, the mice were fasted overnight and the 
body weights were measured. Thereafter, the mice were 
divided into four groups of five mice each. Mice in 
groups 1-4 were treated with 1, 3, 5 & 10 mL/kg b.w. of 
DRHM®, respectively. The experimental mice were 
monitored for 24 h for neurological, behavioural and 
morphological signs of toxicity. Body weights of the 
mice were measured 24 h-post DRHM®-treatment to 
evaluate if there was any significant change in body 
weight. 
 
Study design for animal experiment 
Thirty healthy male Wistar albino rats (180-200 g) 
used for this study were obtained from the 
Department of Zoology and Environmental Biology, 
University of Nigeria, Nsukka. They were maintained 
under standard husbandry conditions of light (12 h) 
and darkness (12 h), room temperature of 26±2oC and 
with free access to commercial rat chow (Vital 
Grower Feed Nigerian Limited) and portable water ad 
libitum. The rats were ethically handled according to 
standard institutional, national and international 
protocols. The study design was approved by the 
Faculty of Biological Sciences Committee on 
Research Ethics (UNN/FBS/EC/0218). After 
acclimatization, the experimental rats were divided 
into six groups of five rats each: Group 1 served as 
normal control (NC). Groups 2-6 were intoxicated by 
single intraperitoneal administration (i.p) of 3 mL/kg 
b.w of 5% v/v of H2O2 on day 0; group 2 that served 
as H2O2 control (HC) was not treated. Groups 3-6 
received 1, 2 & 3 mL/kg/d b.w. of DRHM® (based on 
pilot study result and as well as from manufacturer’s 
recommended dose for human consumers) while 
group 6 received 100 mg/kg/d b.w. of silymarin orally 
(p.o) from days 1 to 14. After an overnight fasting,  
the rats were sacrificed under mild chloroform 
anaesthesia on day 15. Blood was collected from  
each rat through the jugular veins in anticoagulated 
bottle as well as plain tube. Samples collected in 
anticoagulated tubes were subjected to hematological 
analyses while samples collected in plain tubes were 
allowed to clot for 15 min and thereafter centrifuged 
at 3,000 g for 10 min. Serum from each plain sample 
tube was subjected to biochemical analyses of liver, 
lipid peroxidation and antioxidant status. 
 
Determination of hematological and biochemical parameters 
The hematological indices were determined using 
methods described previously13. The biochemical 
parameters evaluated based on standard methods were 
as follows: Serum activities of aspartate (AST) and 
alanine (ALT) aminotransferases14, catalase (CAT)15, 
glutathione peroxidase (GPx)16 and superoxide 
dismutase (SOD)17 and serum concentrations of total 




bilirubin18, reduced glutathione19, vitamins A and C20 
and vitamin E21 and malondialdehyde (MDA)22. 
 
Statistical analysis 
Statistical analysis of primary laboratory data was 
performed by one-way analysis of variance (ANOVA) 
using statistical products and service solutions (SPSS), 
version 20. The results were presented as mean ± 
standard deviation (SD) in Tables. Test of significance 




Phytochemical constituents of DRHM® 
Result of the phytochemical analysis of DRHM®  
is shown in Table 1. The presence of alkaloids (3.50%), 
steroids (1.00%), terpenoids (1.00%), glycosides 
(0.50%), anthocyanins (0.46%), anthraquinones (0.43%), 
saponins (0.40%), flavonoids (0.18%), tannins (0.03%), 
phenols (0.22%) and carotenoids (0.11%) were detected 
in DRHM®. 
 
Acute toxicity profile of DRHM® 
The polyherbal formulation was tolerable up to  
10 mL/kg b.w since there was no significant behavioural 
and body weight change as well as mortality within 
the study period (Table 2). This finding indicates that 
the lethal dose is higher than 10 mL/kg b.w.  
 
Effect of DRHM® on the hematological parameters of H2O2-
intoxicated rats 
Intoxication with H2O2 significantly (p<0.05) 
decreased the PCV, RBC, WBC and platelet counts and 
Hb concentration of the rats in HC when compared with 
NC. However, treatment of intoxicated rats with graded 
doses of DRHM® significantly (p<0.05) increased,  
in a dose-dependent manner, the PCV, RBC, WBC and 
platelet counts and Hb concentration when compared 
with HC. A similar observation was observed when the 
levels in rats treated with silymarin were compared with 
NC and HC. However, the attenuation of H2O2-induced 
alterations in hematological parameters by 3 mL/kg b.w. 
DRHM® was significantly (p<0.05) higher than 100 
mg/kg b.w. silymarin (Table 3). 
 
Effects of DRHM® on the liver status of H2O2-intoxicated rats 
Result presented in Table 4 shows H2O2 intoxication 
significantly (p<0.05) increased the serum AST and 
ALT activities and bilirubin concentration of rats in HC 
when compared with the NC. Meanwhile, treatment 
with DRHM® (1, 2 or 3 mL/kg. b.w.) dose-dependently 
and significantly (p<0.05) decreased serum activities of 
AST and ALT and level of total bilirubin when 
compared with HC. Similarly, intoxicated rats treated 
with 100 mg/kg b.w. silymarin had significantly 
(p<0.05) lower serum activities of AST and ALT and 
level of total bilirubin when compared with HC. 
 
Effect of DRHM® on antioxidant and lipid peroxidation 
status of H2O2-intoxicated rats 
The result as presented in Table 5 shows that H2O2 
intoxication significantly (p<0.05) decreased the 
serum activities of SOD, CAT and GPx of rats in HC 
relative to NC. Meanwhile, treatment of intoxicated 
rats with graded doses of DRHM® significantly 
(p<0.05) increased the SOD, CAT and GPx activities 
when compared with HC. The increase in activities of 
these enzymes were significantly (p<0.05) higher in 
group 5 than in group 6. Injection of H2O2 caused a 
significant (p<0.05) increase in MDA concentration 
of HC compared with NC while treatment of intoxicated 
rats with varied doses of DRHM® significantly 
(p<0.05) decreased the MDA concentration in groups 
3-5. H2O2 control (HC) had a significantly (p<0.05) 
lower GSH concentration than NC. Meanwhile, 
treatment of intoxicated rats with graded doses of 
DRHM® significantly (p<0.05) increased the GSH 
concentration compared with HC, in a manner 
comparable to that of intoxicated rats treated with 
silymarin. H2O2-injection significantly (p<0.05) 
decreased the concentrations of vitamins A, C and E 
in HC when compared with NC. Meanwhile, when 
intoxicated rats were treated with graded doses of 
DRHM®, there were significant (p<0.05) increases in 
the concentrations of vitamins A, C and E in groups 
Table 1 — Phytochemical constituents of DRHM® 













Table 2 — Acute toxicity profile of DRHM® 
Groups Mortality Behavioural and body 
weight changes 
1 mL/kg DRHM® 0/5 Not significant 
3 mL/kg DRHM® 0/5 Not significant 
5 mL/kg DRHM® 0/5 Not significant 
10 mL/kg DRHM® 0/5 Not significant 




3-5 compared with HC. A similar result was obtained 
when intoxicated rats treated with silymarin (Group 6) 
were compared with NC and HC (Table 6). 
 
Discussion 
This study evaluated the effect of DRHM® on 
H2O2-induced hematological and biochemical 
aberrations in rats. Although not a free radical, and 
generally poorly reactive at physiological levels, H2O2 
is still toxic to most cells. It is capable of inactivating 
several enzymes, reacts with iron to form much more 
damaging species such as hydroxyl ion, degrades 
heme proteins including myoglobin, hemoglobin and 
cytochrome C and causes oxidative damage to DNA23. 
The presence of important secondary metabolites  
such as alkaloids, terpenoids, steroids, saponins, 
anthocyanins, glycosides, anthraquinones, tannins, 
flavonoids, phenols and carotenoids in DRHM® 
indicates that it may possess some medicinal values to 
human health. Alkaloids have been reported to exhibit 
anticancer and antimalarial effects while flavonoids, 
tannins, phenolics, saponins and anthocyanins have 
been reported to possess antimicrobial, antioxidant 
and anti-inflammatory effects24. The presence of these 
phytochemicals may support the manufacturer’s claim 
that DRHM® is effective in the management of 
hepatitis and venereal diseases. The result of the 
phytochemical analysis compares well with the 
findings of Khawaya et al.25 & Capasso26 who 
reported the presence of flavonoids in Zingiber 
officinale, and Allium sativum, respectively. Ghosh27 
& Razis et al.28 also reported the presence of 
Table 3 — Effect of DRHM® on the hematological indices of H2O2-intoxicated rats 




Platelet count  
(x106 cells/L) 
Normal control (NC) 43.25±0.96c 14.08±0.83d 302.50±23.27c 5250.00±172.25b 180.00±9.13d 
H2O2 control (HC) 30.50±1.41
a
 10.58±0.34
a 258.50±17.08a 4750.00±157.43a 141.25±8.54a 
H2O2 + 1 mL/kg 
DRHM® 
39.25±2.50b 13.08±0.83b 282.50±13.23b 6850.00±182.84e 161.25±9.31b 
H2O2 + 2 mL/kg 
DRHM® 
40.25±0.50b 13.83±0.43c 310.00±19.58c 6550.00±150.23d 173.75±11.09c 
H2O2 + 3 mL/kg 
DRHM® 
43.75±1.00c 14.58±0.33e 346.25±11.90e 5650.00±258.20c 190.00±4.08d 
H2O2 + 100 mL/kg 
silymarin 
40.00±0.58b 13.33±0.19c 321.25±18.43d 5500.00±115.47c 165.50±3.46b 
Data are mean ± standard deviation (SD) (n = 5). PCV = packed cell volume, Hb = hemoglobin, RBC = red blood cell, WBC = white 
blood cells. Values with different alphabets as superscripts in a column are significantly different at p<0.05. 
 
Table 4 — Effect of DRHM® on the liver status of H2O2-intoxicated rats 
Groups AST (IU/L) ALT (IU/L) Total Bilirubin (mg/dL) 
Normal control (NC) 86.75±2.87b 54.25±2.75a 1.38±0.15b 
H2O2 control (HC) 108.75±7.89
c 93.25±3.10d 2.23±0.17c 
H2O2 + 1 mL/kg DRHM® 89.50±4.80
b 70.00±4.32c 1.45±0.13b 
H2O2 + 2 mL/kg DRHM® 88.50±3.11
b 61.50±2.75b 1.08±0.10a 
H2O2 + 3 mL/kg DRHM® 87.50±3.56
b 53.00±3.37a 1.00±0.18a 
H2O2 + 100 mL/kg silymarin 81.50±3.42
a 54.00±2.16a 1.23±0.13a 
Data are mean ± standard deviation (SD) (n = 5). AST = Aspartate aminotransferase; ALT = alanine aminotransferase. Values with 
different alphabets as superscripts in a column are significantly different at p<0.05. 
 
Table 5 — Effect of DRHM® on antioxidant and lipid peroxidation status of H2O2-intoxicated rats 
Groups SOD (IU/L) CAT (IU/L) GPx (IU/L) MDA (mmol/L) 
     
Normal control (NC) 10.53±0.26c 0.93±0.15b 12.50±0.88c 4.70±0.70a 
H2O2 control (HC) 7.00±0.29
a 0.59±0.28a 5.53±0.49a 7.85±0.43d 
H2O2 + 1 mL/kg DRHM 9.58±0.81
b 1.11±0.07b 8.71±1.21b 5.98±0.10c 
H2O2 + 2 mL/kg DRHM 10.85±0.53
c 1.32±0.08c 12.28±0.99c 5.33±0.17b 
H2O2 + 3 mL/kg DRHM 12.25±0.10
d 1.45±0.08d 15.05±0.94d 4.77±0.08a 
H2O2 + 100 mL/kg silymarin 10.88±0.48
c 0.98±0.07b 11.21±1.08c 5.10±0.56a 
Data are mean ± standard deviation (SD) (n = 5). GPx = Glutathione peroxidase; CAT = Catalase; SOD = Superoxide dismutase; 
MDA = Malondialdehyde. Values with different alphabets as superscripts in a column are significantly different at p<0.05. 
 




flavonoids, alkaloids and anthraquinones in A. 
sativum and Moringa oleifera, which are all 
components of DRHM®. 
The PCV, RBC count and Hb concentration are 
indices used in determining the status, integrity and 
functionality of red blood cells. PCV value indicates 
the transportation capacity of blood; a low PCV value 
indicates low transportation efficiency of the blood 
while a low RBC count indicates anaemia29. The 
significant (p<0.05) reduction in PCV value, RBC 
count and Hb concentration in the H2O2-intoxicated 
and untreated rats (HC) suggests an increased 
erythrocyte destruction and possibly suppression of 
erythrocyte formation by H2O2
30. The observed 
significant (p<0.05) increase in the above parameters 
after treatment with the DRHM® suggests that the 
drug stabilizes the integrity of red cell membranes and 
prevents attack by free radicals. Similarly, the 
observed improvement in red cell indices in the H2O2-
intoxicated and DRHM®-treated rats could also be 
via the stimulation of erythropoietin production and 
the consequent erythropoiesis by the polyherbal 
formulation31. This observation agrees with the results 
of Iranloye32 who recorded an improvement in 
hematological indices of rats treated with A. sativum 
extract; one of the components of DRHM®. H2O2 
also caused a significant (p<0.05) decrease in white 
blood cells of H2O2 control rats when compared with 
the normal control, which suggests a suppressed 
immune response. The dose-dependent increase in 
WBC count observed in the H2O2-intoxicated and 
DRHM®-treated as well as silymarin-treated rats 
indicates an immunostimulatory effect of DRHM®. 
This study is in line with the findings of Aravinda  
et al.33 who reported an increase in WBC count by C. 
papaya leaf extract, a component of DRHM®. 
From the findings of this study, it was observed 
that the administration of H2O2 caused significant 
(p<0.05) hepatic damage as seen in the elevated 
serum activities of AST and ALT and concentration 
of serum total bilirubin. Most toxin-induced liver 
injuries involve oxidative stress as a mechanism of 
cellular damage, and may be identified by rapid 
increase in serum aminotransferases (ALT and AST) 
activities over days, followed by increases in serum 
bilirubin and alkaline phosphatase3. The increase in 
serum activities of these liver marker enzymes 
indicates damage to hepatic cell membrane and 
leakages of intrahepatic enzymes into circulation. 
Treatment of intoxicated rats with DRHM® and 
silymarin normalized the hepatic status by reducing 
the serum activities of liver marker enzymes towards 
normal rats. The decrease in liver enzymes’ activities 
indicates stabilization of hepatocyte membrane by 
DRHM®, preventing the release of intracellular 
content of liver cells to circulation. This effect could 
be attributed to the phytochemical content of 
DRHM®. The result of this study is consistent with 
the findings of Varsha et al.34 and Shetty et al.35 who 
reported a decrease in AST and ALT activities in rats 
treated with M. oleifera leaves and Citrus limon, 
respectively which are two components of the 
polyherbal formulation. Bilirubin is a breakdown 
product of hemoglobin in liver cells, spleen and  
bone marrow. As the liver becomes stressed, serum 
bilirubin level increases, indicating hepatic damage or 
a damage within the liver’s bile duct13. In this study, 
treatment of intoxicated rats with DRHM® 
significantly (p<0.05) reduced the total bilirubin  
level when compared with intoxicated and untreated 
group. Kabera et al.24 reported that plant secondary 
metabolites are effective in protecting against 
oxidative stress-related diseases. The observed 
improvement in hepatic function could therefore, be 
attributed to the phytochemicals present in DRHM®. 
Malondialdehyde (MDA) is a common biomarker 
of lipid peroxidation status5; elevation in MDA level 
indicates the degree of injury in the hepatocytes36. It 
was observed that MDA level increased in serum of 
HC when compared with NC. Meanwhile, treatment 
Table 6 — Effect of DRHM on glutathione and antioxidant vitamins concentrations of H2O2-intoxicated rats 
Groups Reduced glutathione 
(mmol/L) 
Vitamin A (mg/dL) Vitamin C (mmol/L) Vitamin E 
(mmol/L) 
Normal control (NC) 6.73±0.17c 8.88±0.51d 3.90±0.08d 0.51±0.01d 
H2O2 control (HC) 2.68±0.78
a 4.03±0.33a 1.90±0.08a 0.12±0.01a 
H2O2 + 1 mL/kg DRHM 5.65±0.21
b 5.88±0.51b 2.30±0.52b 0.47±0.02c 
H2O2 + 2 mL/kg DRHM 8.80±0.37
d 7.33±1.12c 3.18±0.24c 0.83±0.01e 
H2O2 + 3 mL/kg DRHM 9.48±0.46
e 8.50±0.86d 4.70±0.18e 1.15±0.03f 
H2O2 + 100 mL/kg silymarin 6.05±0.93
c 5.70±0.46b 2.45±0.21b 0.40±0.01b 
Data are mean ± standard deviation (SD) (n = 5). GSH = reduced glutathione. Values with different alphabets as superscripts in a column 
are significantly different at p<0.05. 
 




of intoxicated rats with DRHM® significantly 
(p<0.05) reversed these changes. This suggests that 
the mechanism of the above hepato-curative effect of 
DRHM® is probably due to its anti-lipid peroxidation 
effect. SOD, CAT and GPx are part of the hepatic 
antioxidant defense system that contribute to the 
regulation of oxido-reductive homeostasis and 
mitigation of oxidative attacks on cells37. DRHM® 
significantly (p<0.05) increased SOD, CAT and  
GPx activities in the treated rats. The GSH is an 
intracellular antioxidant which is also a co-factor  
to GPx and glutathione reductase. A low GSH 
concentration exacerbates oxidative assaults, resulting 
in increased membrane and cell damage. The lower 
GSH level observed in the intoxicated and untreated 
rats when compared with normal control might be 
responsible for the reduced GPx activity. Similarly, a 
decrease in CAT activity and leads to reduced  
H2O2 decomposition. H2O2 reacts with free iron, 
leading to production of hydroxyl radical that is very 
toxic to the cells23. Treatment of intoxicated rats with 
DRHM® significantly (p<0.05) increased the GSH 
concentration and this could be responsible for the 
overall improvement in antioxidant status of the 
treated rats. This agrees with the earlier observation 
where plants with hepato-modulatory effects against 
toxicants have also been shown to improve GSH 
concentration38.  
Vitamin E is a very important antioxidant in lipid 
medium; it scavenges free radicals and possibly up-
regulates the expression of antioxidant enzymes. 
Similarly, vitamin A also scavenges free radicals  
in lipid medium and helps maintain pro-oxidant/ 
antioxidant balance. Meanwhile, vitamin C neutralizes 
reactive species in the aqueous medium prior to their 
initiation of lipid peroxidation; it takes part as a  
co-factor in many enzymatic reactions and also  
acts as a plasma localized antioxidant40. In addition, 
vitamin C helps in regeneration of vitamin E to 
protect the cells in lipid medium. The increase  
in antioxidant vitamins concentrations observed in  
the intoxicated and DRHM®-treated rats could be 
attributed to their presence in some of the  
plant components of DRHM®. For example, studies 
have shown that Moringa leaf extract is rich in 
vitamins and carotenoids41. In addition, findings  
from this study suggest that DRHM® is non-lethal up 
to 10 mL/kg body weight dose. This implies that 
DRHM® is relatively safe for human consumption at 
the doses studied. 
Conclusion 
The results of this study support the existing 
knowledge that hydrogen peroxide (H2O2) induces 
cellular oxidative stress via enhancing the production 
and attack of free radicals on cells and weakening of 
body’s antioxidant defense system. The results further 
added that treatment of H2O2-intoxicated rats with 
DRHM® reverses the indices of hematological and 
biochemical aberrations likely by boosting antioxidant 
status and attenuating the cellular oxidative damages 
caused by H2O2 intoxication. The above beneficial 
bioactivities might be attributed to wide varieties of 
phytochemicals detected in DRHM®. This makes the 
herbal drug a potential candidate for the treatment/ 
management of oxidative-stress related conditions. 
The polyherbal formulation was tolerable in mice up 
to 10 mL/kg b.w, showing that the lethal dose is 
above 10 mL/kg b.w and hence, DRHM® is relatively 
safe. However, further studies are warranted to 
evaluate the long-term effects of using this polyherbal 
formulation especially at the molecular level. 
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